Abstract
Epstein–Barr virus (EBV) has been proposed as a possible etiological agent of breast cancer based on 21 reports of EBV in malignant breast tissues. Most of these studies used standard and nested solution polymerase chain reaction (PCR) techniques, both disadvantaged by susceptibility to contamination from laboratory EBV, and the inability to localize the signal to a specific cell type. To avoid these issues, we used in situ molecular methods of viral detection to reassess the frequency of EBV in malignant breast tissue. We used a commercial in situ hybridization (ISH) system with an EBER genome target, and a non-commercial in situ PCR (IS-PCR) method using primers specific for the BamH1 region. The assays were performed on malignant breast tissue sections from 70 breast cancer patients at the M. D. Anderson Cancer Center, Houston, TX. EBV was found in mammary epithelial cells, the cell type from which most breast cancers arise, in 2/70 (2.9%) of specimens using IS-PCR and in none of the specimens using ISH. Based on these findings that EBV was present in human mammary epithelial cells so infrequently, it is unlikely to play a causative role in most types of breast cancer.
Similar content being viewed by others
References
Lespagnard L, Cochaux P, Larsimont D, Degeyter M, Velu T, Heimann R (1995) Absence of Epstein–Barr virus in medullary carcinoma of the breast as demonstrated by immunophenotyping, in situ hybridization and polymerase chain reaction. Am J Clin Pathol 103(4):449–452
Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I (1999) Detection of Epstein–Barr virus in invasive breast cancers. J Natl Cancer Inst 91(16):1376–1381
Brink AA, van Den Brule AJ, van Diest P, Meijer CJ (2000) Re: detection of Epstein–Barr virus in invasive breast cancers. J Natl Cancer Inst 92(8):655–656 author reply 656
Chu JS, Chen CC, Chang KJ (1998) In situ detection of Epstein–Barr virus in breast cancer. Cancer Lett 124(1):53–57
Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM (2001) No significant association of Epstein–Barr virus infection with invasive breast carcinoma. Am J Pathol 159(2):571–578
Deshpande CG, Badve S, Kidwai N, Longnecker R (2002) Lack of expression of the Epstein–Barr virus (EBV) gene products, EBERs, EBNA1, LMP1, and LMP2A in breast cancer cells. Lab Invest 82(9):1193–1199
Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, Gould VE (2002) Demonstration of Epstein–Barr virus in carcinomas of various sites. Cancer Res 62(17):4876–4878
Herrmann K, Niedobitek G (2003) Lack of evidence for an association of Epstein–Barr virus infection with breast carcinoma. Breast Cancer Res 5(1):R13–R17
Kadivar M, Monabati A, Joulaee A, Hosseini N (2011) Epstein–Barr virus and breast cancer: lack of evidence for an association in Iranian women. Pathol Oncol Res. doi:10.1007/s12253-010-9325-z
McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK (2001) Epstein–Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 93(2):148–150
Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, Timms J, Rowlands D, McConkey C, Reynolds GM, Ghataura S, England D, Caroll R, Young LS (2003) Reactivity with A monoclonal antibody to Epstein–Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 63(9):2338–2343
Preciado MV, Chabay PA, De Matteo EN, Gonzalez P, Grinstein S, Actis A, Gass HD (2005) Epstein–Barr virus in breast carcinoma in Argentina. Arch Pathol Lab Med 129(3):377–381. doi:10.1043/1543-2165(2005)129<377:EVIBCI>2.0.CO;2
Ribeiro-Silva A, Ramalho LN, Garcia SB, Zucoloto S (2004) Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein–Barr virus-related breast malignancies? Braz J Med Biol Res 37(1):89–95
Thorne LB, Ryan JL, Elmore SH, Glaser SL, Gulley ML (2005) Real-time PCR measures Epstein–Barr virus DNA in archival breast adenocarcinomas. Diagn Mol Pathol 14(1):29–33
Trabelsi A, Rammeh S, Stita W, Mokni M, Mourou A, Korbi S (2008) Detection of Epstein–Barr virus in breast cancers with lymphoid stroma. Ann Biol Clin (Paris) 66(1):59–62
Arbach H, Viglasky V, Lefeu F, Guinebretiere JM, Ramirez V, Bride N, Boualaga N, Bauchet T, Peyrat JP, Mathieu MC, Mourah S, Podgorniak MP, Seignerin JM, Takada K, Joab I (2006) Epstein–Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol). J Virol 80(2):845–853. doi:10.1128/JVI.80.2.845-853.2006
Dadmanesh F, Peterse JL, Sapino A, Fonelli A, Eusebi V (2001) Lymphoepithelioma-like carcinoma of the breast: lack of evidence of Epstein–Barr virus infection. Histopathology 38(1):54–61
Fawzy S, Sallam M, Awad NM (2008) Detection of Epstein–Barr virus in breast carcinoma in Egyptian women. Clin Biochem 41(7–8):486–492
Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, Buisson M, Gerard H, Reymond MO, Seigneurin JM, Martin PM (2001) Frequency and genome load of Epstein–Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 84(6):783–790
Gaffey MJ, Frierson HF Jr, Mills SE, Boyd JC, Zarbo RJ, Simpson JF, Gross LK, Weiss LM (1993) Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6(6):721–728
Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL (1998) Absence of Epstein–Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 75(4):555–558
Horiuchi K, Mishima K, Ohsawa M, Aozasa K (1994) Carcinoma of stomach and breast with lymphoid stroma: localization of Epstein–Barr virus. J Clin Pathol 47(6):538–540
Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD (2003) Lytic viral replication as a contributor to the detection of Epstein–Barr virus in breast cancer. J Virol 77(24):13267–13274
Kalkan A, Ozdarendeli A, Bulut Y, Yekeler H, Cobanoglu B, Doymaz MZ (2005) Investigation of Epstein–Barr virus DNA in formalin-fixed and paraffin-embedded breast cancer tissues. Med Princ Pract 14(4):268–271
Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Itoh T, Tokunaga M, Eizuru Y, Aikou T (2001) Epstein–Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 64(4):513–518
Labrecque LG, Barnes DM, Fentiman IS, Griffin BE (1995) Epstein–Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 55(1):39–45
Luqmani YA, Shousha S (1995) Presence of Epstein–Barr virus in breast carcinoma. Int J Oncol 6:899–903
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM (2011) Epstein–Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer 104(2):332–337. doi:10.1038/sj.bjc.6606048
Perkins RS, Sahm K, Marando C, Dickson-Witmer D, Pahnke GR, Mitchell M, Petrelli NJ, Berkowitz IM, Soteropoulos P, Aris VM, Dunn SP, Krueger LJ (2006) Analysis of Epstein–Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res 8(6):R70. doi:10.1186/bcr1627
Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, Sugden B (2005) Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev 14(4):809–814
Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL, Yang CC (2005) Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol 75(2):276–281. doi:10.1002/jmv.20267
Xue SA, Lampert IA, Haldane JS, Bridger JE, Griffin BE (2003) Epstein–Barr virus gene expression in human breast cancer: protagonist or passenger? Br J Cancer 89(1):113–119. doi:10.1038/sj.bjc.6601027
Nuovo GJ (1996) PCR in situ hybridization: Protocols and applications. Lippincott-Raven, Philadelphia
Pulvertaft JV (1964) Cytology of Burkitt’s tumor (African lymphoma). Lancet 1(7327):238–240
Pritchett R, Pedersen M, Kieff E (1976) Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology 74(1):227–231
Lindsey JW, Hatfield LM, Crawford MP, Patel S (2009) Quantitative PCR for Epstein–Barr virus DNA and RNA in multiple sclerosis. Mult Scler 15(2):153–158
Pinder SE, Murray S, Ellis IO, Trihia H, Elston CW, Gelber RD, Goldhirsch A, Lindtner J, Cortes-Funes H, Simoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Gusterson BA (1998) The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83(8):1529–1539. doi:10.1002/(SICI)1097-0142(19981015)83:8<1529:AID-CNCR7>3.0.CO;2-V
Glaser SL, Hsu JL, Gulley ML (2004) Epstein–Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 13(5):688–697
Bertrand KA, Birmann BM, Chang ET, Spiegelman D, Aster JC, Zhang SM, Laden F (2010) A prospective study of Epstein–Barr virus antibodies and risk of non-Hodgkin lymphoma. Blood 116(18):3547–3553. doi:10.1182/blood-2010-05-282715
Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, Blaese RM (1984) Abnormally elevated frequency of Epstein–Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 73(6):1789–1795. doi:10.1172/JCI111388
Shannon-Lowe C, Adland E, Bell A, Delecluse H, Rickinson A, Rowe M (2009) Features distinguishing Epstein–Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83:7749–7760
Nuovo GJ (2007) The utility of in situ—based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol 38(8):1123–1136
Acknowledgments
We want to thank the Dr. Susan Love Research Foundation and the Avon Foundation for their support of this project. We thank Shawn Tang in the MDA pathology lab. We also thank the breast cancer patients from M. D. Anderson cancer center who donated their tissues for research.
Conflict of interest
The authors declare that they have no conflicts of interest which may have influenced the results of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baltzell, K., Buehring, G.C., Krishnamurthy, S. et al. Epstein–Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods. Breast Cancer Res Treat 132, 267–274 (2012). https://doi.org/10.1007/s10549-011-1841-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1841-3